To evaluate the effects of a Bacillus coagulans-based product on protein absorption.
- Registration Number
- CTRI/2023/04/051660
- Lead Sponsor
- Abode Biotec India Private Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Subject has provided written and dated informed consent to participate in the study.
2.Subject is willing and able to comply with the protocol.
3.Healthy male/female of age 18-60 years (both inclusive).
4.Subject is in good health as determined by Principal Investigator
1.Subject on protein and/ or probiotic rich diet.
2.Subject is participating in another clinical trial or has received an investigational product within thirty days prior to enrolment.
3.Subject has a history of alcohol or other drug abuse in the past year
4.Subject has any medical condition or uses any medication, nutritional product, dietary supplement or program, which in the opinion of the investigator, might interfere with the conduct of the study or place the subject at risk.
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Change in urine urea nitrogen for Bacillus coagulans-based product on protein absorption <br/ ><br>2.Short Health Scale for GI symptoms (SHS-GI) for Bacillus coagulans-based product on protein absorption <br/ ><br>3.Food frequency questionnaire (FFQs)Timepoint: 8 weeks
- Secondary Outcome Measures
Name Time Method Safety of Bacillus coagulans-based product on protein absorptionTimepoint: 8 Weeks